pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

245 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT774Endpoints578BioPharma Dive223onclive165BioSpace52Fierce Biotech52raps22
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6Hematology
  • Kardigan extends biotech’s streak of big IPOs with $400M haul
    <figure><div><img src="https://imgproxy.divecdn.com/N0psRp1SLHYzWyIWk_EXclLjU7gM7rmyMLxd8U1J6jo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMyODcwOTM0LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • UniQure to file gene therapy for approval, reflecting major shifts at FDA
    <figure><div><img src="https://imgproxy.divecdn.com/cMUj34TqvJiOKaQyGzAGv2T13uG9QyfwV4eRyQ0OOWM/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNTU1X0FEc…
    BioPharma Dive · 1mo ago↗ source
  • Jazz zeroes in on next-gen T cell engagers with AbCellera deal
    <figure><div><img src="https://imgproxy.divecdn.com/-MQ-ipFDv1an0x5BAqQED_kVRHQW-j1q4uZZwHk8OOM/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9ISjBCNlQuanBn.webp"/></div></figur…
← prev
page 5 of 10
next →
6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
BioPharma Dive · 1mo ago
↗ source
  • A new Westlake-backed biotech takes aim at migraines
    <p>Vedana Therapeutics emerged from stealth Wednesday with $46 million to support its mission of developing “anti-PACAP” therapies, an increasingly popular strategy for migraine prevent…
    BioPharma Dive · 1mo ago↗ source
  • Lilly buys non-opioid pain drugmaker 4E
    <figure><div><img src="https://imgproxy.divecdn.com/iu2ROUnJIMOIcb3KSFNQX1F_E37uDKtpsPUAwSV_KTo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDgxMzQwX1huc…
    BioPharma Dive · 1mo ago↗ source
  • Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
    <figure><div><img src="https://imgproxy.divecdn.com/yGRm0BVvV0FRQEiuWFXO6DIhLRxS2AfQRWWXVu3Olwc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTYzNzM0OTUwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
    <figure><div><img src="https://imgproxy.divecdn.com/OJs2JMlOuL6tHcK-0IUh-ddLSEy1yS6jzGMiAhl9CGY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjg4NjcwMjY5LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Edgewise heart drug passes key trial test
    <figure><div><img src="https://imgproxy.divecdn.com/-_-j1ksVvt--CzTabcyO04fqPKqSm8e8ryaYmMbBK0g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzg3Mjk4OTE3LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Neumora depression drug fails; EnGene to cut 50% of staff
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus
    <p>This podcast explores how leading Alzheimer’s experts are working to bridge the gap between clinical trial design and frontline care.</p>
    BioPharma Dive · 1mo ago↗ source
  • Medicare drug price rule may target under-the-skin Keytruda and Opdivo
    <figure><div><img src="https://imgproxy.divecdn.com/yNFj1iOXXiGXHrvNzMITrI7Zf52PfwK1rovRc0StZW8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDQ3NTA1MDAwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Lilly scores early positive data for new JAK drug
    <figure><div><img src="https://imgproxy.divecdn.com/BektaG64-yby8Y5l-Eb4j51Y6ClyucnWH1-PThZhx4E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE0NDc0NzEzLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • J&J multiple myeloma drug gains edge in earlier stage disease
    <figure><div><img src="https://imgproxy.divecdn.com/cm_W-FdbiM9BbB0zoOGzQIxUTIYDjzY9Hg-zhECEdaE/g:nowe:208:253/c:1738:982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZh…
    BioPharma Dive · 1mo ago↗ source
  • Celiac disease is entering a new era of therapeutic innovation
    <p>For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.</p>
    BioPharma Dive · 1mo ago↗ source
  • Planning a successful pivot from lab to clinic
    <p>For sterile injectables, key early decisions can have a significant impact on the products’ development.</p>
    BioPharma Dive · 1mo ago↗ source
  • Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
    <p>In a wide-ranging interview, Abe Ceesay detailed how Rapport built an investor syndicate and why the company is confident it can join the ranks of successful, commercial-stage brain drugmakers.</p>
    BioPharma Dive · 1mo ago↗ source
  • Summit pulls $500M share sale a day after announcing it
    <figure><div><img src="https://imgproxy.divecdn.com/_dT9zKJsCoS0jrFraV8Vdkcut5aCVtKPN0y1PuLlKnE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTUwMzE2NTA1LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
    <figure><div><img src="https://imgproxy.divecdn.com/Sl1QCaU_supqAvtEJA_tXhY8sXexPvdgos3TT-jjIM4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjA1MzM4Nzg3LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Novartis RNA drug acquired in $12B Avidity deal notches a trial win
    <p>The data showed that del-brax, an “antisense oligonucleotide conjugate” being tested against a muscle-wasting disease, met its primary endpoint in a Phase 1/2 study.</p>
    BioPharma Dive · 1mo ago↗ source
  • J&J looks to widen Imaavy’s use; $300M backs rare disease drug launch
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
    <figure><div><img src="https://imgproxy.divecdn.com/-VJqYiEfcoBd7qksclMxxfyJncEOUGAsA4I3KzG8Vpc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzM4Mzc0MDE5LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Ethyreal starts up with $101M and takes aim at a pair of immune diseases
    <figure><div><img src="https://imgproxy.divecdn.com/egbyTu8esim-VjYj5FTvMQUlBrndW-s35OSn02s-EoY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzk4NTE5MTYzLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Sanofi stops immune drug trial in latest research setback
    <p>The failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.</p>
    BioPharma Dive · 1mo ago↗ source
  • Parabilis sets a record with a $670M biotech IPO
    <figure><div><img src="https://imgproxy.divecdn.com/-WtHBsuOT3KcVhU1bnMz7w4Q3nPK_9osZdC3JBWMQKI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy00NjI3NTYxODNfeU9zU…
    BioPharma Dive · 1mo ago↗ source
  • AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source